McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical ...

Oracle is reportedly in the running to acquire Veradigm, formerly Allscripts, according to a Nov. 10 report from Seeking Alpha.

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...

Advanced Diabetes Supply Group: $1.1 billion for the Carlsbad, California, distributor of at-home medical supplies for ...

The city of Baltimore won $266 million in its lawsuit accusing top drug distributors McKesson and Cencora ... his companies November 7, 2024 Medical equipment maker Steris beat second-quarter ...

McKesson (MCK) and Oracle (ORCL) are among the finalists seeking to buy electronic medical records company Veradigm (MDRX), Claire Rychlewski ...

Leading medical distributors McKesson (NYSE:MCK) and Cencora (NYSE:COR) will have to pay $266M in damages to Baltimore after a jury found that the companies were liable for causing the opioid ...

Texas Health Presbyterian Hospital Plano is expanding with a new 696-space parking garage and an upcoming eight-story tower, investing an estimated $343 million to enhance healthcare access for ...

McKesson (MCK) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank. Research shows that stocks ...

In a report released yesterday, Steve Baxter from Wells Fargo maintained a Hold rating on Cencora (COR – Research Report), with a price ...